THE CHINWAGY BUZZ · FIRST VERIFIED WORD
Clinique La Prairie Partners with Zora Biosciences on CERT2 Testing
WHAT CHINWAGY KNOWS
The collaboration
is confirmed.
Zora Biosciences supplies the CERT2 ceramide-based cardiovascular risk assessment, which Clinique La Prairie identifies as an innovative test offered by the clinic.
- Current status
- Official collaboration
- Known availability
- The published source describes the collaboration; timing details remain under review.
- Place
- International, International
- Source checked
- September 18, 2026
FOLLOW THE STORY